BioSpace News Archive

Current and ongoing clinical trials in oncology have shed light on multifactorial pathogenicity of the syndrome cancer cachexia.

Eurofins U.S. Clinical Diagnostics announced the launch date of its pooled PCR test to detect SARS-CoV-2 and significantly reduce the price per PCR test for clients.

IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced that company management will present and participate in several virtual investor conferences

InMode Ltd., a leading global provider of innovative medical technologies, announced consolidated financial results for its second quarter ended June 30, 2020.

Progress across pipeline continues with BT1718 Phase IIa and BT8009 Phase I/II trial initiations on-track for this year

AVROBIO, Inc . (NASDAQ:AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced Geoff MacKay, president and CEO of AVROBIO, will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference at 1:10 p.m. ET on Wednesday, Aug. 12, 2020. A live webcast of the presentation can be accessed under “Events and Presentations” in the Investors

AmerisourceBergen Corporation reported that in its fiscal year 2020 third quarter ended June 30, 2020, revenue increased 0.3 percent year-over-year to $45.4 billion.

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that Derek Maetzold, president and chief executive officer, is scheduled to present a company overview at the Canaccord Genuity 40 th Annual Growth Conference o

Participating investors include funds and accounts managed by BlackRock, GV (formally Google Ventures), Invus, Casdin Capital, Franklin Templeton, Octagon Capital, Perceptive Advisors LLC, Sands Capital, ArrowMark Partners, Venrock Healthcare Capital Partners, PBM Capital and Nolan Capital

Mevion Medical Systems is delighted to be selected to participate in the proton therapy initiative between the city of Córdoba in Andalusia, Spain, the Ministry of Health and Families of Andalusia, and the University of Córdoba to establish an alliance with the Andalusian Health Service and the University Institution.